Quantcast

Latest Becker's muscular dystrophy Stories

2010-03-16 16:10:00

By administering a chemical called a 'molecular band-aid,' U of M researchers were able to prevent heart injury in dystrophic canines MINNEAPOLIS -- Researchers at the University of Minnesota Medical School have discovered a chemical that may, over the long term, protect the hearts of Duchenne muscular dystrophy patients "“ a fatal and most common form of muscular dystrophy in children. The chemical, which Medical School scientists have termed a "molecular band-aid," seeks out tiny...

2010-03-04 08:00:00

Fundraising Event Will Benefit Duchenne Muscular Dystrophy OAK LAWN, Ill., March 4 /PRNewswire-USNewswire/ -- On Friday, March 12, 2010, The Oak Lawn Community High School Spartans gym will be transformed into its own Dancing with the Stars when for one night only, the gym will become Dancing with the Spartans. The event, sponsored by the Senior Class Advisory Board, will mirror the style of the popular TV show: four male teachers and four female teachers chosen by the students will be...

2010-01-21 16:56:51

A study published in today's online edition the American Journal of Human Genetics, allowed the first identification of a new form of adult onset muscular dystrophy. The research team led by Dr. Bernard Brais, neurogeneticist at the Research Centre of the Centre hospitalier de l'Universit© de Montr©al (CRCHUM) and associate professor, Universit© de Montr©al, in collaboration with European collaborators, demonstrated that recessive ANO5 mutations will lead to abnormal...

2010-01-19 13:09:00

Dedicated to Saving Children's Lives in CHASE COMMUNITY GIVING CHALLENGE MIDDLETOWN, Ohio and DALE CITY, Va., Jan. 19 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy together with Trisomy 18 Foundation are among 100 charities that earned a $25,000 grant during Round 1 of the Chase Community Giving Challenge on Facebook. Now in Round 2, Chase Bank has given them the opportunity to compete for an additional $1 Million prize and five $100,000 prizes, to be decided by public...

2010-01-19 08:00:00

SOUTH PLAINFIELD, N.J., Jan. 19 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of an additional clinical trial of ataluren (PTC124®) in boys and young men with nonsense mutation Duchenne/Becker muscular dystrophy (nmDBMD) who have permanently lost the ability to walk independently. This trial is evaluating the best methods for measuring functional abilities in patients who have lost independent mobility. Patients with nmDBMD develop...

2010-01-14 14:45:48

Investigators in The Research Institute at Nationwide Children's Hospital have identified a link between specific modifications of the dystrophin gene and the age of cardiac disease onset in patients with Becker muscular dystrophy (BMD). This information could help clinicians provide early cardiac intervention for BMD patients based on genetic testing results performed on a blood sample. These findings are a result of analysis of the largest number of BMD patients to date and are published in...

2010-01-06 01:20:00

AMSTERDAM, January 6 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it will receive an Innovation Credit of up to EUR 4 million from the Dutch government to support the development of AMT's gene therapy treatment for Duchenne Muscular Dystrophy (DMD). The credit is granted by SenterNovem, an agency of the Dutch Ministry of Economic affairs. "We are delighted to receive this credit for DMD,...

2010-01-05 11:00:00

New Additions to Organization Will Focus on Research, Advocacy, and Outreach MIDDLETOWN, Ohio, Jan. 5 /PRNewswire-USNewswire/ -- Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today that Sharon Hesterlee, Ph.D. and Holly Peay, MS, CGC, will be joining the PPMD staff. Dr. Hesterlee joins PPMD as Senior...

2009-12-08 07:00:00

SOUTH PLAINFIELD, N.J., Dec. 8 /PRNewswire/ -- Data published online in the medical journal Muscle and Nerve support the use of the six-minute walk test (6MWT) as an outcome measure in PTC Therapeutics, Inc.'s ongoing registration-directed clinical trial of ataluren in patients with nonsense mutation Duchenne/Becker muscular dystrophy (nmDMD/BMD). The study results, which will also be published in an upcoming print issue of the journal, characterize the limitations on walking by patients...

2009-11-11 00:00:00

AMSTERDAM, November 11 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related